Breaking newsCOVID-19Research
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
Breaking newsEAN NewsCOVID-19ResearchCOVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management -
Breaking newsCOVID-19ResearchA Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia
A Randomized Trial of Convalescent Plasma in COVID-19 Severe Pneumonia -
Breaking newsCOVID-19Research
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19 -
• Telemedicine consultations can aid effective epilepsy care, even for first visits. -
Caution is warranted with the use of antiseizure medications in the context of COVID-19 illness.
-
This neurology update focuses on mental well-being of people with epilepsy and their caregivers during the COVID-19 pandemic.
-
Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease.
-
This is an interesting work elucidating for the first time a role for ataxin-1 (ATXN1) mutation, traditionally linked to spinocerebellar ataxia-type 1 (SCA1), in the pathogenesis of Experimental Autoimmune Encephalomyelitis (EAE), the rodent model for Multiple Sclerosis (MS) -
The International Restless Legs Syndrome Study Group task force found sufficient evidence to formulate diagnostic criteria for pediatric clinical entity designated “restless sleep disorder”.
-
Societal Impact of Pain (SIP) is an international multi-stakeholder platform. Its long-term priorities are pain indicators, pain education, pain in employment, and pain research. This year traditional SIP Stakeholder Forum was on October 28th, 2020. -
Extra transparency measures for COVID-19 vaccines and therapeutics -
The European Brain Council (EBC) is very pleased to announce the launch of updated disease fact sheets, providing a quick overview of key facts, history, known causes, diagnosis, symptoms and treatment of brain disorders – neurological and mental alike. -
The European Medicines Agency (EMA) has a Healthcare Professionals’ Working Party (HCPWP) in which EAN participates since 2013. Meetings are mostly held together with the Consumers’ and Patients’ Working Party.
-
This year we were especially happy to receive so many good applications and are happy to announce that we could select the below grantees for an entire support of 81 months (instead of 72 as usual).